tiprankstipranks

Andrew Pecora Insider Profile

4 Followers
Andrew Pecora, Director at Lisata Therapeutics, holds 386.28K shares in Lisata Therapeutics (Ticker: LSTA), holds ― shares in Celularity (Ticker: CELU), holds 184.83K shares in Tetralogic Pharma (Ticker: TLOG).
tipranks
Andrew Pecora

Andrew Pecora
Lisata Therapeutics (LSTA)
Director

Ranked #93,137 out of 97,489 Corporate Insiders

Profitable Transactions

0%
0 out of 4 Profitable Transactions

Average Return

-77.80%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$1M
99.85%
0.15%
0.00%
A breakdown of Andrew Pecora's holdings

Insider Roles

Lisata Therapeutics
(LSTA)
Director
Tetralogic Pharma
(TLOG)
Director
Celularity
(CELU)
President
Roles that Andrew Pecora holds in companies

Most Profitable Insider Trade

Stock:
Tetralogic Pharma
(TLOG)
Rating:Informative Buy
Date:Nov 19, 2014 - Nov 19, 2015
Return:-64.70%
The most profitable trade made by Andrew Pecora

Andrew Pecora's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Lisata Therapeutics
Jun 23, 2016
Director
Uninformative Buy
$1.20M
Celularity
President
Tetralogic Pharma
Jul 14, 2015
Director
Informative Buy
133.81K
$1.85K
VYNT
Vyant Bio
Nov 20, 2013
Informative Sell
713.16K
$463.85
List of latest transactions for each holding click on a transaction to see Andrew Pecora's performance on stock

Andrew Pecora insider profile FAQ

What is the percentage of profitable transactions made by Andrew Pecora?
The percentage of profitable transactions made by Andrew Pecora is 0%.
    What is the average return per transaction made by Andrew Pecora?
    The average return per transaction made by Andrew Pecora is -77.80%.
      What stocks does Andrew Pecora hold?
      Andrew Pecora holds: LSTA, CELU, TLOG, VYNT stocks.
        What was Andrew Pecora’s latest transaction?
        Andrew Pecora latest transaction was an Uninformative Buy of ―.
          What was Andrew Pecora's most profitable transaction?
          Andrew Pecora’s most profitable transaction was an Informative Buy of TLOG stock on November 19, 2014. The return on the trade was -64.70%.
            What is Andrew Pecora's role in Lisata Therapeutics?
            Andrew Pecora's role in Lisata Therapeutics is Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.